NCT07413159 The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
| NCT ID | NCT07413159 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Texas Southern University |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 480 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2028-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 480 participants in total. It began in 2026-06-01 with a primary completion date of 2028-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study, "Check, Monitor, Control Hypertension in Older African American Adults," is a randomized clinical trial designed to improve blood pressure control among African American adults aged 55 years and older in the Greater Houston area. Hypertension disproportionately affects African Americans, contributing to higher rates of cardiovascular disease and stroke. This project aims to improve clinical and behavioral outcomes through a 24-month intervention combining pharmacist-led counseling and Community Health Worker (CHW) support.
Eligibility Criteria
Inclusion Criteria: Individuals are eligible to the study if they are: * 55 years or older * Have at least 2 high blood pressure readings ≥ 130/80 mmHg within one month * Past Medical History of hypertension \> 1 year * Taking at least 1 antihypertensive medication * Independent Activities of Daily Livings (ADL) and instrumental Activities of Daily Livings (iADL) * Have a SmartPhone * Live within the Greater Houston Metropolitan Areas * Able to speak English Exclusion criteria: * Unable to verbalize comprehension of study or impaired cognitive function (e.g. dementia) * Not able to monitor blood pressure at home * Plans to relocate outside Houston within the next year
Contact & Investigator
Ivy O Poon, Pharm.D., M.S., BCPS
PRINCIPAL INVESTIGATOR
Texas Southern University
Frequently Asked Questions
Who can join the NCT07413159 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07413159 currently recruiting?
Yes, NCT07413159 is actively recruiting participants. Contact the research team at ivy.poon@tsu.edu for enrollment information.
Where is the NCT07413159 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07413159 clinical trial?
NCT07413159 is sponsored by Texas Southern University. The principal investigator is Ivy O Poon, Pharm.D., M.S., BCPS at Texas Southern University. The trial plans to enroll 480 participants.